Revenue of $85.9 billion for the First Quarter, a 5.5% Increase Year-Over-YearFirst Quarter GAAP Diluted EPS of $2.87 and Adjusted Diluted EPS of $4.08Adjusted Operating Income Guidance Raised to ...
Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that PharosAI, a research consortium uniting four leading UK institutions, will use the 10x Genomics Xenium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results